Your privacy is important to us. Cookies are very small text files that are stored on your computer when you visit a website. We use cookies and other tracking technologies for a variety of purposes and to enhance your online experience on our website. You can change your preferences and decline certain types of cookies to be stored on your computer while browsing our website. You can also remove any cookies already stored on your computer, but keep in mind that deleting cookies may prevent you from using parts of our website. You can check our privacy policy page for more information.
Always Active
These cookies are essential to provide you with services available through our website and to enable you to use certain features of our website. Without these cookies, we cannot provide you certain services on our website; as a result these cookies do not require your consent.
These cookies are used to show advertising that is likely to be of interest to you based on your browsing habits. These cookies, as served by our content and/or advertising providers, may combine information they collected from our website with other information they have independently collected relating to your web browser's activities across their network of websites.
These cookies are used to provide you with a more personalized experience on our website and to remember choices you make when you use our website. For example, we may use functionality cookies to remember your language preferences or remember your login details.
These cookies are used to collect information to analyze the traffic to our website and how visitors are using our website. For example, these cookies may track things such as how long you spend on the website or the pages you visit which helps us to understand how we can improve our website site for you.
Always Active
These cookies are essential to provide you with services available through our website and to enable you to use certain features of our website. Without these cookies, we cannot provide you certain services on our website; as a result these cookies do not require your consent.
These cookies are used to show advertising that is likely to be of interest to you based on your browsing habits. These cookies, as served by our content and/or advertising providers, may combine information they collected from our website with other information they have independently collected relating to your web browser's activities across their network of websites.
These cookies are used to provide you with a more personalized experience on our website and to remember choices you make when you use our website. For example, we may use functionality cookies to remember your language preferences or remember your login details.
These cookies are used to collect information to analyze the traffic to our website and how visitors are using our website. For example, these cookies may track things such as how long you spend on the website or the pages you visit which helps us to understand how we can improve our website site for you.
I'm Not Average: Matt May Have Cancer, but Cancer Doesn’t Have Him
His diagnosis in December 2009 was a complete shock and the prognosis wasn’t good. With treatment, he faced a five-year survival rate of less than five percent.
I'm Not Average: Matt May Have Cancer, but Cancer Doesn’t Have Him.
Share This
When Matt Ellefson developed a cough, he didn’t think much of it. He just assumed it was caused by the cold winter air, but as the weeks passed by his cough lingered.
Then he began coughing up blood.
Within hours of going to the ER, Matt was diagnosed with advanced non-small cell lung cancer, and the prognosis wasn’t good. With treatment, he faced a five-year survival rate of less than five percent.
His diagnosis in December 2009 was a complete shock. He was a non-smoker and lived a healthy and fit lifestyle. Soon after being diagnosed, Matt enrolled in an aggressive clinical trial. After five months, his cancer went into remission.
One year later his cancer resurfaced and it had spread. Treatment options were extremely slim. While waiting for his doctor for follow-up testing, he learned about a targeted gene therapy that was recently approved. However, the odds were still against him. Patients typically developed resistance to the medicine in eight months.
Three years later, Matt is living an active, happy life controlling his disease thanks to advances and innovations in cancer medicines. He runs marathons, participates in cycling competitions, and explores the world with his family. If he does become resistant to his current medicine, there have been three new drugs approved, so now he has other options.
He has hope because of the progress made in cancer research.
Matt’s story is part of PhRMA’s new campaign, I’m Not Average, to share inspirational stories from individuals about the powerful impact advances and innovations in cancer medicines have had on their lives.
For more information on the I’m Not Average campaign, please visit www.phrma.org/cancer.
Join the conversation about advances and innovations in cancer medicines using the hashtag #NotAverage.
This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.